Archives: Agenda

Strategic Priorities for Tobacco and Alternatives Companies

  • How tobacco and nicotine companies are responding to declining combustible consumption and increasing regulatory pressure across vaping and oral nicotine 
  • Why nicotine replacement therapy (NRT), wellness-oriented pouches, and adjacent functional categories are emerging as key innovation and growth spaces 
  • How consumer expectations around value, accessibility, health, and performance are reshaping the future of nicotine and alternative products 
  • What the latest consumer, innovation, patent, deals, and social sentiment data reveal about the next phase of disruption in the nicotine industry 

PMTA Expectations for Nicotine Pouches

  • Understanding FDA expectations for nicotine pouch PMTAs: core requirements and key differentiators
  • Designing efficient PMTA study packages while managing regulatory and scientific risk
  • Where nicotine pouch PMTAs commonly fall down and practical strategies to mitigate those risks

Prize Draw

Delegates will enter a draw to win prizes.